Publication | Closed Access

C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors

Molecular PharmacologyMedicinal ChemistryC17,20-lyase InhibitorsBiochemistryMedicineNatural SciencesStructure–activity RelationshipsDrug DevelopmentPharmacologyPharmaceutical ChemistryNovel C17,20-lyase InhibitorsDrug Discovery